← Back to Influence Map
Entity DossierOrganization
AMGEN INC.
DC · US
Healthcare/Biotechnology
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$8,030,000
Connections
25
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$20.5MMMMMedicare/Medicaid
$20.3MTAXTaxation/Internal Revenue Code
$16.9MCPTCopyright/Patent/Trademark
$15.9MTARTariff
$8.6MBUDBudget/Appropriations
$1.7MLBRLabor/Employment
$840KIMMImmigration
$600KLAWLaw Enforcement/Crime
$420KPHAPharmacy
$120KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$15.1M
MILLER STRATEGIES, LLC$840K
TODD STRATEGY GROUP$840K
WILLIAMS AND JENSEN, PLLC$840K
TARPLIN, DOWNS & YOUNG, LLC$780K
TIBER CREEK GROUP$780K
BGR GOVERNMENT AFFAIRS$700K
EMPIRE CONSULTING GROUP$600K
CAPITOL COUNSEL LLC$600K
TIBER CREEK HEALTH STRATEGIES, INC.$500K
HILLNORTH LLC$275K
SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA$240K
RICCHETTI INCORPORATED$120K
WASHINGTON ADVOCACY GROUP$115K
JEFFREY J. KIMBELL & ASSOCIATES, INC.$75K
AVENUE SOLUTIONS$50K
MICHAEL J. LAMOUREUX$10K
FEDERAL HEALTH COUNSEL, LLC$0
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Lobbied on | Inflation Reduction Act - Energy Provisions (H.R.5376) | LDA filing: lobbied on Inflation Reduction Act - Energy, period 1st Quarter (Jan 1 - Mar 31), reported amount $3,330,000 | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000 | Source |
| Retained | EMPIRE CONSULTING GROUP | Hired EMPIRE CONSULTING GROUP to lobby on PBM Reform Act | Source |
| Retained | TODD STRATEGY GROUP | Hired TODD STRATEGY GROUP to lobby on NIH March-In Rights | Source |
| Lobbied on | BIOSECURE Act (H.R.8333/S.3558) | LDA filing: lobbied on BIOSECURE Act, period 2nd Quarter (Apr 1 - June 30), reported amount $2,740,000 | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Retained | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby on Pharmaceuticals | Source |
| Retained | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Hired JEFFREY J. KIMBELL & ASSOCIATES, INC. to lobby on Pharmaceuticals | Source |
| Retained | HILLNORTH LLC | Hired HILLNORTH LLC to lobby on Pharmaceuticals | Source |
| Retained | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby on Pharmaceuticals | Source |
| Retained | Capitol Counsel, LLC | Hired CAPITOL COUNSEL LLC to lobby on Pharmaceuticals | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-0240: Medicare Program: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney I | Source |
| Lobbied on | Inflation Reduction Act - Drug Pricing Provisions (H.R.5376) | LDA filing: lobbied on IRA Drug Pricing Provisions, period 1st Quarter (Jan 1 - Mar 31), reported amount $3,330,000 | Source |
| Retained | TIBER CREEK HEALTH STRATEGIES, INC. | Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on Pharmaceuticals | Source |
| Retained | CAPITOL COUNSEL LLC | Hired CAPITOL COUNSEL LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | WILLIAMS AND JENSEN, PLLC | Hired WILLIAMS AND JENSEN, PLLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | FEDERAL HEALTH COUNSEL, LLC | Hired FEDERAL HEALTH COUNSEL, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | BGR GOVERNMENT AFFAIRS | Hired BGR GOVERNMENT AFFAIRS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | MILLER STRATEGIES, LLC | Hired MILLER STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA | Hired SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA to lobby (4th Quarter (Oct 1 - Dec 31) 2023) | Source |
| Retained | WASHINGTON ADVOCACY GROUP | Hired WASHINGTON ADVOCACY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2024) | Source |
| Retained | RICCHETTI INCORPORATED | Hired RICCHETTI INCORPORATED to lobby (2nd Quarter (Apr 1 - June 30) 2024) | Source |
| Retained | AVENUE SOLUTIONS | Hired AVENUE SOLUTIONS to lobby (2nd Quarter (Apr 1 - June 30) 2026) | Source |
| Retained | MICHAEL J. LAMOUREUX | Hired MICHAEL J. LAMOUREUX to lobby (2nd Quarter (Apr 1 - June 30) 2026) | Source |
| Parent of | HORIZON THERAPEUTICS | Horizon Therapeutics was acquired by Amgen in 2023 | Source |